Previous close | 22.60 |
Open | 22.60 |
Bid | 21.60 |
Ask | 26.40 |
Strike | 75.00 |
Expiry date | 2025-01-17 |
Day's range | 22.50 - 22.60 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Today we meet with British CEO Paul Hudson to find out how he plans to build the Sanofi of tomorrow.
There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.
In recent trading sessions, the French stock market has shown resilience, with the CAC 40 Index modestly increasing by 0.11%. This uptick reflects cautious optimism among investors following the European Central Bank's decision to cut interest rates for the first time in five years, signaling a potentially more supportive environment for equities. In this context, dividend stocks can be particularly appealing as they offer potential income in addition to price appreciation opportunities...